| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |